Publications 2013-2017

Publications of the LBC for Cardiovascular Research 2017

Only original papers or reviews on which either a PI or one of his/her co-workers associated with the respective project appear as first, last or corresponding author (highlighted in bold) are considered to be publications of the cluster.

Publications ASC:

Schima H. Welcome message – 44th ESAO and 7th IFAO Congress, 6-9 September 2017, Vienna, Austria. Int J Artif Organs. 2017 Aug 22;40(8):367. IF 1.169
Marko C, Xhelili E, Lackner T, Zimpfer D, Schima H, Moscato F. Exercise performance during the first two years after left ventricular assist device implantation. ASAIO J. 2017 Jul/Aug;63(4):408-413. IF 2.190

Publications INFO:

Hohensinner PJ, Baumgartner J, Kral-Pointner JB, Uhrin P, Ebenbauer B, Thaler B, Doberer K, Stojkovic S, Demyanets S, Fischer MB, Huber K, Schabbauer G, Speidl WS, Wojta J. PAI-1 (plasminogen activator inhibitor-1) expression renders alternatively activated human macrophages proteolytically quiescent. Arterioscler Thromb Vasc Biol. 2017 Oct;37(10):1913-1922. IF 6.607
Hohensinner PJ, Takacs N, Kaun C, Thaler B, Krychtiuk KA, Pfaffenberger S, Aliabadi A, Zuckermann A, Huber K, Wojta J. Urokinase plasminogen activator protects cardiac myocytes from oxidative damage and apoptosis via hOGG1 induction. Apoptosis. 2017 Aug;22(8):1048-1055. IF 3.833
Krychtiuk KA, Honeder MC, Lenz M, Maurer G, Wojta J, Heinz G, Huber K, Speidl WS. Copeptin Predicts Mortality in Critically Ill Patients. PLoS One. 2017 Jan 24;12(1):e0170436. IF 2.806
Krychtiuk KA, Kaun C, Hohensinner PJ, Stojkovic S, Seigner J, Kastl SP, Zuckermann A, Eppel W, Rauscher S, de Martin R, Maurer G, Huber K, Wojta J, Speidl WS. Anti-thrombotic and pro-fibrinolytic effects of levosimendan in human endothelial cells in vitro. Vascul Pharmacol. 2017 Mar;90:44-50. IF 3.718
Stojkovic S, Thulin Å, Hell L, Thaler B, Rauscher S, Baumgartner J, Gröger M, Ay C, Demyanets S, Neumayer C, Huk I, Spittler A, Huber K, Wojta J, Siegbahn A, Åberg M. IL-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets. Thromb Haemost. 2017 Jun 28;117(7):1379-1390. IF 5.627
Wojta J. What ADAMTS13 does in the liver…. Thromb Haemost. 2017 Jan 5;117(1):6. IF 5.627

Publications REM:

Kiss A, Tratsiakovich Y, Mahdi A, Yang J, Gonon AT, Podesser BK, Pernow J. Vagal nerve stimulation reduces infarct size via a mechanism involving the alpha-7 nicotinic acetylcholine receptor and downregulation of cardiac and vascular arginase. Acta Physiol (Oxf). 2017 Nov;221(3):174-181. IF 4.867
Trescher K, Gleiss A, Boxleitner M, Dietl W, Kassal H, Holzinger C, Podesser BK. Short-term clinical outcomes for intermittent cold versus intermittent warm blood cardioplegia in 2200 adult cardiac surgery patients. J Cardiovasc Surg (Torino). 2017 Feb;58(1):105-112. IF 2.179

Publications BIO:

Arfvidsson J, Ahlin F, Vargas KG, Thaler B, Wojta J, Huber K. Monocyte subsets in myocardial infarction: A review. Int J Cardiol. 2017 Mar 15;231:47-53. IF 6.189
Chan MY, Neely ML, Roe MT, Goodman SG, Erlinge D, Cornel JH, Winters KJ, Jakubowski JA, Zhou C, Fox KAA, Armstrong PW, White HD, Prabhakaran D, Ohman EM, Huber K; TRILOGY ACS Investigators. Temporal biomarker profiling reveals longitudinal changes in risk of death or myocardial infarction in non-ST-segment elevation acute coronary syndrome. Clin Chem. 2017 Jul;63(7):1214-1226. IF 8.008
Farhan S, Clare RM, Jarai R, Giugliano RP, Lokhnygina Y, Harrington RA, Kristin Newby L, Huber K. Fasting glucose, NT-proBNP, treatment with eptifibatide, and outcomes in non-ST-segment elevation acute coronary syndromes: An analysis from EARLY ACS. Int J Cardiol. 2017 Apr 1;232:264-270. IF 6.189
Freynhofer MK, Iliev L, Bruno V, Rohla M, Egger F, Weiss TW, Hübl W, Willheim M, Wojta J, Huber K. Platelet turnover predicts outcome after coronary intervention. Thromb Haemost. 2017 May 3;117(5):923-933. IF 5.627
Haller PM, Kiss A, Wojta J, Podesser BK, Huber K. [Cardioprotection via the arm?: How a blood pressure cuff decreases infarct sizes]. Herz. 2017 Sep;42(6):565-572. IF 0.776
Halvorsen S, Storey RF, Rocca B, Sibbing D, Ten Berg J, Grove EL, Weiss TW, Collet JP, Andreotti F, Gulba DC, Lip GYH, Husted S, Vilahur G, Morais J, Verheugt FWA, Lanas A, Al-Shahi Salman R, Steg PG, Huber K; ESC Working Group on Thrombosis. Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J. 2017 May 14;38(19):1455-1462. IF 20.212
Huber K, Verheugt FW. Bivalirudin in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: uncertainties almost clarified. EuroIntervention. 2017 Mar 20;12(16):1930-1932. IF 5.193
Huber K, Ducrocq G, Hamm CW, van ‘t Hof A, Lapostolle F, Coste P, Gordini G, Steinmetz J, Verheugt FWA, Adgey J, Nibbe L, Kaniĉ V, Clemmensen P, Zeymer U, Bernstein D, Prats J, Deliargyris EN, Gabriel Steg P. Early clinical outcomes as a function of use of newer oral P2Y(12) inhibitors versus clopidogrel in the EUROMAX trial. Open Heart. 2017 Nov 28;4(2):e000677.
Jäger B, Farhan S, Rohla M, Christ G, Podczeck-Schweighofer A, Schreiber W, Laggner AN, Weidinger F, Stefenelli T, Delle-Karth G, Kaff A, Maurer G, Huber K; Vienna STEMI Registry Group. Clinical predictors of patient related delay in the VIENNA ST-elevation myocardial infarction network and impact on long-term mortality. Eur Heart J Acute Cardiovasc Care. 2017 Apr;6(3):254-261.
Piackova E, Jäger B, Farhan S, Christ G, Schreiber W, Weidinger F, Stefenelli T, Delle-Karth G, Kaff A, Maurer G, Huber K; Vienna STEMI Registry Group. Gender differences in short- and long-term mortality in the Vienna STEMI registry. Int J Cardiol. 2017 Oct 1;244:303-308.
Sibbing D, Angiolillo DJ, Huber K. Antithrombotic therapy for acute coronary syndrome: Past, present and future. Thromb Haemost. 2017 Jun 28;117(7):1240-1248. IF 5.627
Tentzeris I, Farhan S, Freynhofer MK, Rohla M, Jarai R, Vogel B, Baumgartner-Parzer S, Nürnberg M, Geppert A, Wessely E, Wojta J, Huber K, Kautzky-Willer A. Usefulness of elevated levels of growth differentiation factor-15 to classify patients with acute coronary syndrome having percutaneous coronary intervention who would benefit from high-dose statin therapy. Am J Cardiol. 2017 Sep 1;120(5):747-752. IF 3.398
Tscharre M, Jäger B, Farhan S, Christ G, Schreiber W, Weidinger F, Stefenelli T, Delle-Karth G, Kaff A, Maurer G, Huber K; Vienna STEMI Registry Group. Impact of time of admission on short- and long-term mortality in the Vienna STEMI registry. Int J Cardiol. 2017 Oct 1;244:1-6. IF 6.189
Tscharre M, Hauser C, Rohla M, Freynhofer MK, Wojta J, Huber K, Weiss TW. Epicardial adipose tissue and cardiovascular outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2017 Dec;6(8):750-752.
Tscharre M, Egger F, Machata M, Rohla M, Michael N, Neumayr M, Zweiker R, Hajos J, Adlbrecht C, Suppan M, Helmreich W, Eber B, Huber K, Weiss TW. Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry. PLoS One. 2017 Jun 20;12(6):e0179349. IF 2.806

Associated publications of the LBC for Cardiovascular Research 2017

Original papers and reviews on which PIs or project-associated co-workers appear as co-authors (highlighted in bold) are considered to be associated publications of the cluster and are listed below.

Aass T, Stangeland L, Chambers DJ, Hallström S, Rossmann C, Podesser BK, Urban M, Nesheim K, Haaverstad R, Matre K, Grong K. Myocardial energy metabolism and ultrastructure with polarizing and depolarizing cardioplegia in a porcine model. Eur J Cardiothorac Surg. 2017 Jul 1;52(1):180-188. IF 3.759
Alfonso F; Editors’ Network European Society of Cardiology Task Forc; Editors’ Network European Society of Cardiology Task Force. Data sharing. Eur Heart J. 2017 May 7;38(18):1361-1363. IF 20.212
Alfonso F, Adamyan K, Artigou JY, Aschermann M, Boehm M, Buendia A, Chu PH, Cohen A, Dei Cas L, Dilic M, Doubell A, Echeverri D, Enç N, Ferreira-González I, Filipiak KJ, Flammer A, Fleck E, Gatzov P, Ginghina C, Goncalves L, Haouala H, Hassanein M, Heusch G, Huber K, Hulín I, Ivanusa M, Krittayaphong R, Lau CP, Marinskis G, Mach F, Felipe Moreira L, Nieminen T, Oukerraj L, Perings S, Pierard L, Potpara T, Reyes-Caorsi W, Rim SJ, Rødevand O, Saade G, Sander M, Shlyakhto E, Timuralp B, Tousoulis D, Ural D, Piek JJ, Varga A, Lüscher TF; Editors’ Network European Society of Cardiology Task Force. Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors. Implications for the editors’ network. Egypt Heart J. 2017 Jun;69(2):89-94.
Alfonso F, Adamyan K, Artigou JY, Aschermann M, Boehm M, Buendia A, Chu PH, Cohen A, Cas LD, Dilic M, Doubell A, Echeverri D, Enç N, Ferreira-González I, Filipiak KJ, Flammer A, Fleck E, Gatzov P, Ginghina C, Goncalves L, Haouala H, Hassanein M, Heusch G, Huber K, Hulín I, Ivanusa M, Krittayaphong R, Lau CP, Marinskis G, Mach F, Moreira LF, Nieminen T, Oukerraj L, Perings S, Pierard L, Potpara T, Reyes-Caorsi W, Rim SJ, Rødevand O, Saade G, Sander M, Shlyakhto E, Timuralp B, Tousoulis D, Ural D, Piek JJ, Varga A, Lüscher TF. Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors. Implications for the editors’ network. Turk Kardiyol Dern Ars. 2017 Jun;45(4):377-384.
Alfonso F, Adamyan K, Artigou JY, Aschermann M, Boehm M, Buendia A, Chu PH, Cohen A, Cas LD, Dilic M, Doubell A, Echeverri D, Enç N, Ferreira-González I, Filipiak KJ, Flammer A, Fleck E, Gatzov P, Ginghina C, Goncalves L, Haouala H, Hassanein M, Heusch G, Huber K, Hulín I, Ivanusa M, Krittayaphong R, Lau CP, Marinskis G, Mach F, Moreira LF, Nieminen T, Oukerraj L, Perings S, Pierard L, Potpara T, Reyes-Caorsi W, Rim SJ, Rødevand O, Saade G, Sander M, Shlyakhto E, Timuralp B, Tousoulis D, Ural D, Piek JJ, Varga A, Lüscher TF. Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors. Implications for the editors’ network. Acta Cardiol Sin. 2017 May;33(3):315-322. IF 0.342
Alfonso F, Adamyan K, Artigou JY, Aschermann M, Boehm M, Buendia A, Chu PH, Cohen A, Cas LD, Dilic M, Doubell A, Echeverri D, Enç N, Ferreira-González I, Filipiak KJ, Flammer A, Fleck E, Gatzov P, Ginghina C, Goncalves L, Haouala H, Hassanein M, Heusch G, Huber K, Hulín I, Ivanusa M, Krittayaphong R, Lau CP, Marinskis G, Mach F, Moreira LF, Nieminen T, Oukerraj L, Perings S, Pierard L, Potpara T, Reyes-Caorsi W, Rim SJ, Rødevand O, Saade G, Sander M, Shlyakhto E, Timuralp B, Tousoulis D, Ural D, Piek JJ, Varga A, Lüscher TF. Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors. Implications for the editors’ network. Arch Cardiol Mex. 2017 Apr – Jun;87(2):101-107.
Alfonso F, Adamyan K, Artigou JY, Aschermann M, Boehm M, Buendia A, Chu PH, Cohen A, Cas LD, Dilic M, Doubell A, Echeverri D, Enç N, Ferreira-González I, Filipiak KJ, Flammer A, Fleck E, Gatzov P, Ginghina C, Goncalves L, Haouala H, Hassanein M, Heusch G, Huber K, Hulín I, Ivanusa M, Krittayaphong R, Lau CP, Marinskis G, Mach F, Moreira LF, Nieminen T, Oukerraj L, Perings S, Pierard L, Potpara T, Reyes-Caorsi W, Rim SJ, Rødevand O, Saade G, Sander M, Shlyakhto E, Timuralp B, Tousoulis D, Ural D, Piek JJ, Varga A, Lüscher TF. Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors. Implications for the editors’ network. Arq Bras Cardiol. 2017 May;108(5):390-395. IF 1.186
Alfonso F, Adamyan K, Artigou JY, Aschermann M, Boehm M, Buendia A, Chu PH, Cohen A, Cas LD, Dilic M, Doubell A, Echeverri D, Enç N, Ferreira-González I, Filipiak KJ, Flammer A, Fleck E, Gatzov P, Ginghina C, Goncalves L, Haouala H, Hassanein M, Heusch G, Huber K, Hulín I, Ivanusa M, Krittayaphong R, Lau CP, Marinskis G, Mach F, Moreira LF, Nieminen T, Oukerraj L, Perings S, Pierard L, Potpara T, Reyes-Caorsi W, Rim SJ, Rødevand O, Saade G, Sander M, Shlyakhto E, Timuralp B, Tousoulis D, Ural D, Piek JJ, Varga A, Lüscher TF. Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors. Implications for the editors’ network. Kardiol Pol. 2017;75(5):512-517. IF 1.341
Andreas M, Moayedifar R, Wieselthaler G, Wolzt M, Riebandt J, Haberl T, Angleitner P, Schlöglhofer T, Wiedemann D, Schima H, Laufer G, Zimpfer D. Increased thromboembolic events with dabigatran compared with vitamin K antagonism in left ventricular assist device patients: A randomized controlled pilot trial. Circ Heart Fail. 2017 May;10(5). pii: e00370 IF 6.372
Auer J, Huber K, Granger CB. Interruption of non-vitamin K antagonist anticoagulants in patients undergoing planned invasive procedures: how long is long enough? Eur Heart J. 2017 Aug 14;38(31):2440-2443. IF 20.212
Bagai A, Goodman SG, Cantor WJ, Vicaut E, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Lapostolle F, Lassen JF, Merkely B, Storey RF, Ten Berg JM, Zeymer U, Diallo A, Hamm CW, Tsatsaris A, El Khoury J, Van’t Hof AW, Montalescot G. Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC study. Am Heart J. 2018 Feb;196:56-64. IF 4.436
Beygui F, Castren M, Brunetti ND, Rosell-Ortiz F, Christ M, Zeymer U, Huber K, Folke F, Svensson L, Bueno H, Van’t Hof A, Nikolaou N, Nibbe L, Charpentier S, Swahn E, Tubaro M, Goldstein P. [Pre-hospital management of patients with chest pain and/or dyspnoea of cardiac origin. ]. Recenti Prog Med. 2017 Jan;108(1):27-51.
Djinović Z, Pavelka R, Tomić M, Sprinzl G, Plenk H, Losert U, Bergmeister H, Plasenzotti R. In-vitro and in-vivo measurement of the animal’s middle ear acoustical response by partially implantable fiber-optic sensing system. Biosens Bioelectron. 2018 Apr 30;103:176-181. IF 7.780
Eilenberg W, Stojkovic S, Kaider A, Kozakowski N, Domenig CM, Burghuber C, Nanobachvili J, Huber K, Klinger M, Neumayer C, Huk I, Wojta J, Demyanets S. NGAL and MMP-9/NGAL as biomarkers of plaque vulnerability and targets of statins in patients with carotid atherosclerosis. Clin Chem Lab Med. 2017 Nov 27;56(1):147-156. IF 3.432
Eilenberg W, Stojkovic S, Piechota-Polanczyk A, Kaider A, Kozakowski N, Weninger WJ, Nanobachvili J, Wojta J, Huk I, Demyanets S, Neumayer C. Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment. Cardiovasc Diabetol. 2017 Aug 8;16(1):98. IF 4.752
Fabris E, Van’t Hof A, Hamm CW, Lapostolle F, Lassen JF, Goodman SG, Ten Berg JM, Bolognese L, Cequier A, Chettibi M, Hammett CH, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Cantor WJ, Rousseau H, Vicaut E, Montalescot G. Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial. EuroIntervention. 2017 May 15;13(1):69-77. IF 5.193
Fellner B, Rohla M, Jarai R, Smetana P, Freynhofer MK, Egger F, Zorn G, Weiss TW, Huber K, Geppert A. Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2017 Jun;6(4):348-358.
Giannitsis E, Mair J, Christersson C, Siegbahn A, Huber K, Jaffe AS, Peacock WF, Plebani M, Thygesen K, Möckel M, Mueller C, Lindahl B; Biomarker Study Group of the European Society of Cardiology (ESC) Acute Cardiovascular Care Association (ACCA). How to use D-dimer in acute cardiovascular care. Eur Heart J Acute Cardiovasc Care. 2017 Feb;6(1):69-80.
Giugliano RP, Keech A, Murphy SA, Huber K, Tokgozoglu SL, Lewis BS, Ferreira J, Pineda AL, Somaratne R, Sever PS, Pedersen TR, Sabatine MS. Clinical efficacy and safety of evolocumab in high-risk patients receiving a statin: Secondary analysis of patients with low LDL cholesterol levels and in those already receiving a maximal-potency statin in a randomized clinical trial. JAMA Cardiol. 2017 Dec 1;2(12):1385-1391.
Hadzijusufovic E, Albrecht-Schgoer K, Huber K, Hoermann G, Grebien F, Eisenwort G, Schgoer W, Herndlhofer S, Kaun C, Theurl M, Sperr WR, Rix U, Sadovnik I, Jilma B, Schernthaner GH, Wojta J, Wolf D, Superti-Furga G, Kirchmair R, Valent P. Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site. Leukemia. 2017 Nov;31(11):2388-2397. IF 11.702
Hafner C, Wu J, Soto-Gonzalez L, Kaun C, Stojkovic S, Wojta J, Tretter V, Markstaller K, Klein KU. Moderate hyperoxia induces inflammation, apoptosis and necrosis in human umbilical vein endothelial cells: An in-vitro study. Eur J Anaesthesiol. 2017 Mar;34(3):141-149. IF 3.570
Hafner C, Wu J, Tiboldi A, Hess M, Mitulovic G, Kaun C, Krychtiuk KA, Wojta J, Ullrich R, Tretter EV, Markstaller K, Klein KU. Hyperoxia induces inflammation and cytotoxicity in human adult cardiac myocytes. Shock. 2017 Apr;47(4):436-444. IF 3.113
Hasun M, Dörler J, Edlinger M, Alber H, Von Lewinski D, Eber B, Roithinger FX, Berger R, Siostrzonek P, Grimm G, Benzer W, Wintersteller W, Huber K, Schuchlenz H, Weidinger F; Austrian Acute PCI Investigators. In-hospital outcome comparing bivalirudin to heparin in real-world primary percutaneous coronary intervention. Am J Cardiol. 2017 Dec 15;120(12):2135-2140. IF 3.398
Herta J, Wang WT, Höftberger R, Breit S, Kneissl S, Bergmeister H, Ferraz-Leite H. An experimental animal model for percutaneous procedures used in trigeminal neuralgia. Acta Neurochir (Wien). 2017 Jul;159(7):1341-1348. IF 1.881
Holnthoner W, Bonstingl C, Hromada C, Muehleder S, Zipperle J, Stojkovic S, Redl H, Wojta J, Schöchl H, Grillari J, Weilner S, Schlimp CJ. Endothelial cell-derived extracellular vesicles size-dependently exert procoagulant activity detected by thromboelastometry. Sci Rep. 2017 Jun 16;7(1):3707. IF 4.259
Koller L, Richter B, Winter MP, Sulzgruber P, Potolidis C, Liebhart F, Mörtl D, Berger R, Goliasch G, Lang I, Wojta J, Hülsmann M, Niessner A. Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failure. J Clin Lipidol. 2017 Jan – Feb;11(1):178-184. IF 5.812
Koller L, Stojkovic S, Richter B, Sulzgruber P, Potolidis C, Liebhart F, Mörtl D, Berger R, Goliasch G, Wojta J, Hülsmann M, Niessner A. Soluble urokinase-type plasminogen activator receptor improves risk prediction in patients with chronic heart failure. JACC Heart Fail. 2017 Apr;5(4):268-277. IF 8.493
Kopin D, Jones WS, Sherwood MW, Wojdyla DM, Wallentin L, Lewis BS, Verheugt FWA, Vinereanu D, Bahit MC, Halvorsen S, Huber K, Parkhomenko A, Granger CB, Lopes RD, Alexander JH. Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial. Am Heart J. 2018 Mar;197:133-141. IF 4.436
Leiss H, Salzberger W, Jacobs B, Gessl I, Kozakowski N, Blüml S, Puchner A, Kiss A, Podesser BK, Smolen JS, Stummvoll GH. MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupus. PLoS One. 2017 Jul 18;12(7):e0181015. IF 2.806
Liu Z, Silvain J, Kerneis M, Barthélémy O, Payot L, Choussat R, Sabouret P, Cohen M, Pollack CV Jr, Goldstein P, Zeymer U, Huber K, Vicaut E, Collet JP, Montalescot G. Intravenous enoxaparin versus unfractionated heparin in elderly patients undergoing primary percutaneous coronary intervention: An analysis of the randomized ATOLL trial. Angiology. 2017 Jan;68(1):29-39. IF 3.085
Lowenstern A, Storey RF, Neely M, Sun JL, Angiolillo DJ, Cannon CP, Himmelmann A, Huber K, James SK, Katus HA, Morais J, Siegbahn A, Steg PG, Wallentin L, Becker RC; PLATO Investigators. Platelet-related biomarkers and their response to inhibition with aspirin and p2y(12)-receptor antagonists in patients with acute coronary syndrome. J Thromb Thrombolysis. 2017 Aug;44(2):145-153. IF 2.142
Macfelda K, Kapeller B, Holly A, Podesser BK, Losert U, Brandes K, Goettel P, Mueller J. Bioelectrical signals improve cardiac function and modify gene expression of extracellular matrix components. ESC Heart Fail. 2017 Aug;4(3):291-300.
Mair J, Lindahl B, Giannitsis E, Huber K, Thygesen K, Plebani M, Möckel M, Müller C, Jaffe AS; Biomarker Study Group of the European Society of Cardiology Acute Cardiovascular Care Association. Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care? Eur Heart J Acute Cardiovasc Care. 2017 Jun;6(4):321-328.
Möckel M, Giannitsis E, Mueller C, Huber K, Jaffe AS, Mair J, Plebani M, Thygesen K, Lindahl B; Biomarker Study Group of the European Society of Cardiology Acute Cardiovascular Care Association. Editor’s Choice-Rule-in of acute myocardial infarction: Focus on troponin. Eur Heart J Acute Cardiovasc Care. 2017 Apr;6(3):212-217.
Mueller C, Giannitsis E, Möckel M, Huber K, Mair J, Plebani M, Thygesen K, Jaffe AS, Lindahl B; Biomarker Study Group of the ESC Acute Cardiovascular Care Association. Rapid rule out of acute myocardial infarction: novel biomarker-based strategies. Eur Heart J Acute Cardiovasc Care. 2017 Apr;6(3):218-222.
Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, Horton RP, Buchbinder M, Neuzil P, Gordon NT, Holmes DR Jr.; PREVAIL and PROTECT AF Investigators. 5-year outcomes after left atrial appendage closure: From the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017 Dec 19;70(24):2964-2975. IF 19.896
Rubboli A, Agewall S, Huber K, Lip GYH. New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose. Eur J Intern Med. 2017 May;40:e11-e12. IF 2.960
Schiele F, Gale CP, Bonnefoy E, Capuano F, Claeys MJ, Danchin N, Fox KA, Huber K, Iakobishvili Z, Lettino M, Quinn T, Rubini Gimenez M, Bøtker HE, Swahn E, Timmis A, Tubaro M, Vrints C, Walker D, Zahger D, Zeymer U, Bueno H. Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care. 2017 Feb;6(1):34-59.
Schreiber C, Eilenberg M, Kiss A, Bergmeister H, Podesser B, Mascherbauer J, Bonderman D. Preserved right ventricular integrity in a new telemetric rat model of severe pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2017 Nov 1;313(5):L957-L963. IF 4.281
Schreiber C, Eilenberg MS, Panzenboeck A, Winter MP, Bergmeister H, Herzog R, Mascherbauer J, Lang IM, Bonderman D. Combined oral administration of L-arginine and tetrahydrobiopterin in a rat model of pulmonary arterial hypertension. Pulm Circ. 2017 Apr 4;7(1):89-97. IF 2.178
Schwabl P, Hambruch E, Seeland BA, Hayden H, Wagner M, Garnys L, Strobel B, Schubert TL, Riedl F, Mitteregger D, Burnet M, Starlinger P, Oberhuber G, Deuschle U, Rohr-Udilova N, Podesser BK, Peck-Radosavljevic M, Reiberger T, Kremoser C, Trauner M. The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction. J Hepatol. 2017 Apr;66(4):724-733. IF 12.486
Sibbing D, Aradi D, Jacobshagen C, Gross L, Trenk D, Geisler T, Orban M, Gori T, Hadamitzky M, Merkely B, Kiss RG, Komócsi A, Dézsi CA, Thalmeier A, Löw A, Holdt L, Teupser D, Ince H, Felix SB, Parma R, Malek L, Horstkotte J, Baylacher M, Schwinger R, Rieber J, Mudra H, Hausleiter J, Huber K, Neumann FJ, Koltowski L, Huczek Z, Mehilli J, Massberg S; TROPICAL-ACS Investigators. A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial. Thromb Haemost. 2017 Jan 5;117(1):188-195. IF 5.627
Sibbing D, Aradi D, Jacobshagen C, Gross L, Trenk D, Geisler T, Orban M, Hadamitzky M, Merkely B, Kiss RG, Komócsi A, Dézsi CA, Holdt L, Felix SB, Parma R, Klopotowski M, Schwinger RHG, Rieber J, Huber K, Neumann FJ, Koltowski L, Mehilli J, Huczek Z, Massberg S; TROPICAL-ACS Investigators. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial. Lancet. 2017 Oct 14;390(10104):1747-1757. IF 47.831
Siller-Matula JM, Petre A, Delle-Karth G, Huber K, Ay C, Lordkipanidzé M, De Caterina R, Kolh P, Mahla E, Gersh BJ. Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: A systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care. 2017 Dec;6(8):753-770.
Stanetic BM, Ostojic M, Campos CM, Marinkovic J, Farooq V, Kovacevic-Preradovic T, Huber K, Serruys PW. ApPropriateness of myocardial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study. Int J Cardiol. 2017 Jan 15;227:478-484. IF 6.189
Sulzgruber P, El-Hamid F, Koller L, Forster S, Goliasch G, Wojta J, Niessner A. Long-term outcome and risk prediction in patients suffering acute myocardial infarction complicated by post-infarction cardiac rupture. Int J Cardiol. 2017 Jan 15;227:399-403. IF 6.189
Sulzgruber P, Koller L, Winter MP, Richter B, Blum S, Korpak M, Hülsmann M, Goliasch G, Wojta J, Niessner A. The impact of CD4(+)CD28(null) T-lymphocytes on atrial fibrillation and mortality in patients with chronic heart failure. Thromb Haemost. 2017 Jan 26;117(2):349-356. IF 5.627
Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Savonitto S, Torremante P, Vrints C, Schneider S, Desch S, Zeymer U; CULPRIT-SHOCK Investigators. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017 Dec 21;377(25):2419-2432. IF 72.406
Wiedemann D, Schlöglhofer T, Riebandt J, Neuner M, Tschernko E, Schima H, Zimpfer D. From research lab to clinical routine of MCS. ASAIO J. 2017 Jul/Aug;63(4):e51. IF 2.190
Wiedemann D, Schlöglhofer T, Riebandt J, Neuner M, Tschernko E, Schima H, Zimpfer D. Myocardial recovery in peripartum cardiomyopathy after hyperprolactinemia treatment on BIVAD. ASAIO J. 2017 Jan/Feb;63(1):109-111. IF 2.190
Wilflingseder J, Jelencsics K, Bergmeister H, Sunzenauer J, Regele H, Eskandary F, Reindl-Schwaighofer R, Kainz A, Oberbauer R. miR-182-5p inhibition ameliorates ischemic acute kidney injury. Am J Pathol. 2017 Jan;187(1):70-79. IF 4.057
Winter MP, Blessberger H, Alimohammadi A, Pavo N, Huber K, Wojta J, Lang IM, Wiesbauer F, Goliasch G. Long-term outcome and risk assessment in premature acute myocardial infarction: A 10-year follow-up study. Int J Cardiol. 2017 Aug 1;240:37-42. IF 6.189
Young C, Laufer G, Kocher A, Solinas M, Alamanni F, Polvani G, Podesser BK, Aramendi JI, Arribas J, Bouchot O, Livi U, Massetti M, Terp K, Giot C, Glauber M. One-year outcomes after rapid-deployment aortic valve replacement. J Thorac Cardiovasc Surg. 2018 Feb;155(2):575-585. IF 4.446

Publications of the LBC for Cardiovascular Research 2016

Publications ASC:

Granegger M, Aigner P, Haberl T, Mahr S, Tamez DA, Graham J, Nunez NJ, Schima H, Moscato F. Interaction of a transapical miniaturized ventricular assist device with the left ventricle: hemodynamic evaluation and visualization in an isolated heart setup. Artif Organs. 2016 Dec;40(12):1113-1120. IF 1.993
Granegger M, Masetti M, Laohasurayodhin R, Schloeglhofer T, Zimpfer D, Schima H, Moscato F. Continuous monitoring of aortic valve opening in rotary blood pump patients. IEEE Trans Biomed Eng. 2016 Jun;63(6):1201-7. IF 2.468
Granegger M, Schlöglhofer T, Ober H, Zimpfer D, Schima H, Moscato F. Daily life activity in patients with left ventricular assist devices. Int J Artif Organs. 2016 Jan;39(1):22-7. IF 1.008
Moscato F, Gross C, Haller M, Marko C, Zimpfer D, Schima H. Track H. Cardio technology. Biomed Tech (Berl). 2016 Sep 1;61(s1):70-80.
Schima H, Dimitrov K, Zimpfer D. Debate: creating adequate pulse with a continuous flow ventricular assist device: can it be done and should it be done? Probably not, it may cause more problems than benefits! Curr Opin Cardiol. 2016 May;31(3):337-42. IF 2.158
Zimpfer D, Strueber M, Aigner P, Schmitto JD, Fiane AE, Larbalestier R, Tsui S, Jansz P, Simon A, Schueler S, Moscato F, Schima H. Evaluation of the HeartWare ventricular assist device Lavare cycle in a particle image velocimetry model and in clinical practice. Eur J Cardiothorac Surg. 2016 Nov;50(5):839-848. IF 2.803

Publications INFO:

Ahlin F, Arfvidsson J, Vargas KG, Stojkovic S, Huber K, Wojta J. MicroRNAs as circulating biomarkers in acute coronary syndromes: A review. Vascul Pharmacol. 2016 Jun;81:15-21. IF 2.500
Gyöngyösi M. Is increased homocysteine level a false trail or an accomplice to saphenous venous graft degeneration? Anatol J Cardiol. 2016 Nov;16(11):874. IF 1.414
Gyöngyösi M, Giurgea GA, Syeda B, Charwat S, Marzluf B, Mascherbauer J, Jakab A, Zimba A, Sárközy M, Pavo N, Sochor H, Graf S, Lang I, Maurer G, Bergler-Klein J; MYSTAR investigators.. Long-term outcome of combined (percutaneous intramyocardial and intracoronary) application of autologous bone marrow mononuclear cells post myocardial infarction: The 5-Year MYSTAR Study. PLoS One. 2016 Oct 20;11(10):e0164908 IF 3.057
Gyöngyösi M, Wojakowski W, Navarese EP, Moye LÀ; ACCRUE Investigators.. Meta-analyses of human cell-based cardiac regeneration therapies: Controversies
in meta-analyses results on cardiac cell-based regenerative studies. Circ Res. 2016 Apr 15;118(8):1254-63. IF 11.551
Hohensinner PJ, Ebenbauer B, Kaun C, Maurer G, Huber K, Wojta J. Reduced Ang2 expression in aging endothelial cells. Biochem Biophys Res Commun. 2016 Jun 3;474(3):447-51. IF 2.371
Hohensinner PJ, Kaun C, Buchberger E, Ebenbauer B, Demyanets S, Huk I, Eppel W, Maurer G, Huber K, Wojta J. Age intrinsic loss of telomere protection via TRF1 reduction in endothelial cells. Biochim Biophys Acta. 2016 Feb;1863(2):360-7. IF 5.128
Krychtiuk KA, Lenz M, Koller L, Honeder MC, Wutzlhofer L, Zhang C, Chi L, Maurer G, Niessner A, Huber K, Wojta J, Heinz G, Speidl WS. Monocyte subset distribution is associated with mortality in critically ill patients. Thromb Haemost. 2016 Oct 28;116(5):949-957. IF 5.255
Mandic L, Traxler D, Gugerell A, Zlabinger K, Lukovic D, Pavo N, Goliasch G, Spannbauer A, Winkler J, Gyöngyösi M. Molecular imaging of angiogenesis in cardiac regeneration. Curr Cardiovasc Imaging Rep. 2016;9(10):27.
Montanari E, Stojkovic S, Kaun C, Lemberger CE, de Martin R, Rauscher S, Gröger M, Maurer G, Neumayer C, Huk I, Huber K, Demyanets S, Wojta J. Interleukin-33 stimulates GM-CSF and M-CSF production by human endothelial cells. Thromb Haemost. 2016 Aug 1;116(2):317-27. IF 5.255
Pavo N, Wurm R, Goliasch G, Novak JF, Strunk G, Gyöngyösi M, Poglitsch M, Säemann MD, Hülsmann M. Renin-angiotensin system fingerprints of heart failure with reduced ejection fraction. J Am Coll Cardiol. 2016 Dec 27;68(25):2912-2914. IF 17.759
Pavo N, Samaha E, Sabdyusheva I, von Strandmann RP, Stahnke S, Plass CA, Zlabinger K, Lukovic D, Jambrik Z, Pavo IJ, Bergler-Klein J, Gray WA, Maurer G, Gyöngyösi M. Coating of intravascular balloon with paclitaxel prevents constrictive remodeling of the dilated porcine femoral artery due to inhibition of intimal and media fibrosis. J Mater Sci Mater Med. 2016 Aug;27(8):131. IF 2.272
Stojkovic S, Kaun C, Basilio J, Rauscher S, Hell L, Krychtiuk KA, Bonstingl C, de Martin R, Gröger M, Ay C, Holnthoner W, Eppel W, Neumayer C, Huk I, Huber K, Demyanets S, Wojta J. Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation. Sci Rep. 2016 May 4;6:25171. IF 5.228
Thaler B, Hohensinner PJ, Krychtiuk KA, Matzneller P, Koller L, Brekalo M, Maurer G, Huber K, Zeitlinger M, Jilma B, Wojta J, Speidl WS. Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans. Sci Rep. 2016 Jul 22;6:30162. IF 5.228
Wojta J. Cenderitide: a multivalent designer-peptide-agonist of particulate guanylyl cyclase receptors with considerable therapeutic potential in cardiorenal disease states. Eur Heart J Cardiovasc Pharmacother. 2016 Apr;2(2):106-7.

Publications REM:

Bergmeister K, Podesser B. Acceptance of animal research in our science community. Version 2. F1000Res. 2016 Mar 4 [revised 2016 Jul 8];5:282.
Kremer J, Muschitz GK, Aumayr K, Moser P, Szabo G, Weymann A, Zuckermann A, Podesser BK. Influence of antithymocyte globulin treatment of brain-dead organ donor on inflammatory response in cardiac grafts: an experimental study in mice. Transpl Int. 2016 Dec;29(12):1329-1336. IF 2.835
Taggart DP, Altman DG, Gray AM, Lees B, Gerry S, Benedetto U, Flather M; ART Investigators.. Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts. N Engl J Med. 2016 Dec 29;375(26):2540-9. IF 59.558

Publications BIO:

Farhan S, Vogel B, Tentzeris I, Jarai R, Freynhofer MK, Smetana P, Egger F, Kautzky-Willer A, Huber K. Contrast induced acute kidney injury in acute coronary syndrome patients: A single centre experience. Eur Heart J Acute Cardiovasc Care. 2016 Feb;5(1):55-61.
Haller PM, Kiss A, Wojta J, Podesser BK, Huber K. [Cardioprotection via the arm?: How a blood pressure cuff decreases infarct sizes]. Herz. 2016 Oct 26. IF 0.751
Jäger B, Farhan S, Rohla M, Christ G, Podczeck-Schweighofer A, Schreiber W, Laggner AN, Weidinger F, Stefenelli T, Delle-Karth G, Kaff A, Maurer G, Huber K; Vienna STEMI Registry Group.. Clinical predictors of patient related delay in the VIENNA ST-elevation myocardial infarction network and impact on long-term mortality. Eur Heart J Acute Cardiovasc Care. 2017 Apr;6(3):254-261.
Rohla M, Tentzeris I, Freynhofer MK, Farhan S, Jarai R, Egger F, Weiss TW, Wojta J, Geppert A, Kastrati A, Stone GW, Huber K. Impact of bivalirudin on mortality and bleeding complications in acute coronary syndrome patients undergoing invasive revascularization: A real world experience. Wien Klin Wochenschr. 2016 Dec;128(23-24):906-915. IF 0.836
Vargas KG, Kassem M, Mueller C, Wojta J, Huber K. Copeptin for the early rule-out of non-ST-elevation myocardial infarction. Int J Cardiol. 2016 Nov 15;223:797-804. IF 4.638
Vogel B, Farhan S, Hahne S, Kozanli I, Kalla K, Freynhofer MK, Jarai R, Kautzky-Willer A, Huber K. Sex-related differences in baseline characteristics, management and outcome in patients with acute coronary syndrome without ST-segment elevation. Eur Heart J Acute Cardiovasc Care. 2016 Aug;5(4):347-53.
Weihs V, Szücs D, Fellner B, Eber B, Weihs W, Lambert T, Metzler B, Titscher G, Hochmayer B, Dechant C, Eder V, Siostrzonek P, Leisch F, Pichler M, Pachinger O, Gaul G, Weber H, Podczeck-Schweighofer A, Nesser HJ, Huber K. Electrocardiogram changes and wall motion abnormalities in the acute phase of Tako-Tsubo syndrome. Eur Heart J Acute Cardiovasc Care. 2016 Oct;5(6):481-488.

Publications SDG:

Enayati M, Eilenberg M, Grasl C, Riedl P, Kaun C, Messner B, Walter I, Liska R, Schima H, Wojta J, Podesser BK, Bergmeister H. Biocompatibility assessment of a new biodegradable vascular graft via in vitro co-culture approaches and in vivo model. Ann Biomed Eng. 2016 Nov;44(11):3319-3334. IF 2.887
Haider T, Plasenzotti R, Bergmeister H, Mach G, Kleinpeter G, Aguilar-Perez M, Sherif C. New mechanical thrombectomy model in the rabbit: A feasibility study. J Neurosci Methods. 2016 Sep 15;271:139-42. IF 2.053
Sherif C, Herbich E, Plasenzotti R, Bergmeister H, Windberger U, Mach G, Sommer G, Holzapfel GA, Haider T, Krssak M, Kleinpeter G. Very large and giant microsurgical bifurcation aneurysms in rabbits: Proof of feasibility and comparability using computational fluid dynamics and biomechanical testing. J Neurosci Methods. 2016 Aug 1;268:7-13. IF 2.053

Associated publications of the LBC for Cardiovascular Research 2016

Original papers and reviews on which PIs or project-associated co-workers appear as co-authors (highlighted in bold) are considered to be associated publications of the cluster and are listed below.

Alexander JH, Andersson U, Lopes RD, Hijazi Z, Hohnloser SH, Ezekowitz JA, Halvorsen S, Hanna M, Commerford P, Ruzyllo W, Huber K, Al-Khatib SM, Granger CB, Wallentin L; Apixaban for Reduction of Stroke and Other Thromboembolic Complications in Atrial Fibrillation (ARISTOTLE) Investigators. Apixaban 5 mg twice daily and clinical outcomes in patients with atrial fibrillation and advanced age, low body weight, or high creatinine: a secondary analysis of a randomized clinical trial. JAMA Cardiol. 2016 Sep 1;1(6):673-81.
Arras MM, Jana R, Mühlstaedt M, Maenz S, Andrews J, Su Z, Grasl C, Jandt KD. In situ formation of nanohybrid shish-kebabs during electrospinning for the creation of hierarchical shish-kebab structures. Macromolecules 2016; 49(9):3550-3558 IF: 5.800
Bartko J, Schoergenhofer C, Schwameis M, Buchtele N, Wojta J, Schabbauer G, Stiebellehner L, Jilma B. Dexamethasone inhibits endotoxin-induced coagulopathy in human lungs. J Thromb Haemost. 2016 Dec;14(12):2471-2477. IF 5.565
Beer L, Mildner M, Gyöngyösi M, Ankersmit HJ. Peripheral blood mononuclear cell secretome for tissue repair. Apoptosis. 2016 Dec;21(12):1336-1353. IF 3.592
De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Collet JP, Halvorsen S, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Ricci F, Sibbing D, Siegbahn A, Storey RF, Ten Berg J, Verheugt FW, Weitz JI. Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease. Thromb Haemost. 2016 Apr;115(4):685-711. IF 5.255
Dimitrov K, Riebandt J, Haberl T, Wiedemann D, Simon P, Laufer G, Schima H, Zimpfer D. High-intensity transient signals in the outflow graft and thrombosis of a HeartWare left ventricular assist device. Ann Thorac Surg. 2016 Mar;101(3):e83-5. IF 3.201
Eilenberg W, Stojkovic S, Piechota-Polanczyk A, Kaun C, Rauscher S, Gröger M, Klinger M, Wojta J, Neumayer C, Huk I, Demyanets S. Neutrophil gelatinase-associated lipocalin (NGAL) is associated with symptomatic carotid atherosclerosis and drives pro-inflammatory state in vitro. Eur J Vasc Endovasc Surg. 2016 May;51(5):623-31. IF 2.912
Farhan S, Freynhofer MK, Brozovic I, Bruno V, Vogel B, Tentzeris I, Baumgartner-Parzer S, Huber K, Kautzky-Willer A. Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study. Cardiovasc Diabetol. 2016 Apr 8;15:60. IF 4.534
Hayer S, Bauer G, Willburger M, Sinn K, Alasti F, Plasenzotti R, Shvets T, Niederreiter B, Aschauer C, Steiner G, Podesser BK, Smolen JS, Redlich K. Cartilage damage and bone erosion are more prominent determinants of functional impairment in longstanding experimental arthritis than synovial inflammation. Dis Model Mech. 2016 Nov 1;9(11):1329-1338. IF 4.316
Hauser JA, Demyanets S, Rusai K, Goritschan C, Weber M, Panesar D, Rindler L, Taylor AM, Marculescu R, Burch M, Wojta J, Michel-Behnke I. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure. Heart. 2016 Oct 15;102(20):1633-9. IF 5.693
Hemmeryckx B, Hohensinner P, Swinnen M, Heggermont W, Wojta J, Lijnen HR. Antioxidant treatment improves cardiac dysfunction in a murine model of premature aging. J Cardiovasc Pharmacol. 2016 Nov;68(5):374-382. IF 2.462
Jilma-Stohlawetz P, Quehenberger P, Schima H, Stoiber M, Knöbl P, Steinlechner B, Felli A, Jilma B. Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent. Thromb Res. 2016 Jan;137:196-201. IF 2.320
Kapeller B, Mueller J, Losert U, Podesser BK, Macfelda K. Microcurrent stimulation promotes reverse remodelling in cardiomyocytes. ESC Heart Fail. 2016 Jun;3(2):122-130.
Koller L, Hohensinner P, Sulzgruber P, Blum S, Maurer G, Wojta J, Hülsmann M, Niessner A. Prognostic relevance of circulating endothelial progenitor cells in patients with chronic heart failure. Thromb Haemost. 2016 Aug 1;116(2):309-16. IF 5.255
Kriz R, Freynhofer MK, Weiss TW, Egger F, Gruber SC, Eisenburger P, Wojta J, Huber K, Koch J. Safety and efficacy of pharmacological cardioversion of recent-onset atrial fibrillation: a single-center experience. Am J Emerg Med. 2016 Aug;34(8):1486-90. IF 1.504
Lambert T, Nahler A, Rohla M, Reiter C, Grund M, Kammler J, Blessberger H, Kypta A, Kellermair J, Schwarz S, Starnawski JA, Lichtenauer M, Weiss TW, Huber K, Steinwender C. Endpoint design for future renal denervation trials – Novel implications for a new definition of treatment response to renal denervation. Int J Cardiol. 2016 Oct 1;220:273-8. IF 4.638
Lincoff AM, Mehran R, Povsic TJ, Zelenkofske SL, Huang Z, Armstrong PW, Steg PG, Bode C, Cohen MG, Buller C, Laanmets P, Valgimigli M, Marandi T, Fridrich V, Cantor WJ, Merkely B, Lopez-Sendon J, Cornel JH, Kasprzak JD, Aschermann M, Guetta V, Morais J, Sinnaeve PR, Huber K, Stables R, Sellers MA, Borgman M, Glenn L, Levinson AI, Lopes RD, Hasselblad V, Becker RC, Alexander JH; REGULATE-PCI Investigators.. Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomized clinical trial. Lancet. 2016 Jan 23;387(10016):349-56. IF 44.002
Montalescot G, van ‘t Hof AW, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Collet JP, Goodman SG, Hammett CJ, Huber K, Janzon M, Lapostolle F, Lassen JF, Licour M, Merkely B, Salhi N, Silvain J, Storey RF, Ten Berg JM, Tsatsaris A, Zeymer U, Vicaut E, Hamm CW; ATLANTIC Investigators.. Effect of pre-hospital ticagrelor during the first 24 h after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: the ATLANTIC-H²⁴ analysis. JACC Cardiovasc Interv. 2016 Apr 11;9(7):646-56. IF 7.630
Nijenhuis VJ, Bennaghmouch N, Hassell M, Baan J Jr, van Kuijk JP, Agostoni P, van ‘t Hof A, Kievit PC, Veenstra L, van der Harst P, van den Heuvel AF, den Heijer P, Kelder JC, Deneer VH, van der Kley F, Onorati F, Collet JP, Maisano F, Latib A, Huber K, Stella PR, Ten Berg JM. Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation. Am Heart J. 2016 Mar;173:77-85. IF 4.332
Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S, Baumgartner H, Gaemperli O, Achenbach S, Agewall S, Badimon L, Baigent C, Bueno H, Bugiardini R, Carerj S, Casselman F, Cuisset T, Erol Ç, Fitzsimons D, Halle M, Hamm C, Hildick-Smith D, Huber K, Iliodromitis E, James S, Lewis BS, Lip GY, Piepoli MF, Richter D, Rosemann T, Sechtem U, Steg PG, Vrints C, Luis Zamorano J; Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology.. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016 Jan 14;37(3):267-315. IF 15.064
Rohla M, Haberfeld H, Sinzinger H, Kritz H, Tscharre M, Freynhofer MK, Huber K, Weiss TW. Systematic screening for cardiovascular risk at pharmacies. Open Heart. 2016 Sep 19;3(2):e000497.
Rohla M, Haberfeld H, Tscharre M, Huber K, Weiss TW. Awareness, treatment, and control of hypertension in Austria: a multicentre cross-sectional study. J Hypertens. 2016 Jul;34(7):1432-40. IF 5.062
Rohla M, Nahler A, Lambert T, Reiter C, Gammer V, Grund M, Blessberger H, Kammler J, Kypta A, Saleh K, Huber K, Steinwender C, Weiss TW. Predictors of response to renal denervation for resistant arterial hypertension: a single center experience. J Hypertens. 2016 Jan;34(1):123-9. IF 5.062
Schneider KH, Aigner P, Holnthoner W, Monforte X, Nürnberger S, Rünzler D, Redl H, Teuschl AH. Decellularized human placenta chorion matrix as a favorable source of small-diameter vascular grafts. Acta Biomater. 2016;29:125-134. IF: 6.025
Schrutka L, Distelmaier K, Hohensinner P, Sulzgruber P, Lang IM, Maurer G, Wojta J, Hülsmann M, Niessner A, Koller L. Impaired high-density lipoprotein anti-oxidative function is associated with outcome in patients with chronic heart failure. J Am Heart Assoc. 2016 Dec 21;5(12). IF 5.117
Thiele H, Desch S, Piek JJ, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Noc M, Huber K, Fuernau G, de Waha S, Meyer-Saraei R, Schneider S, Windecker S, Savonitto S, Briggs A, Torremante P, Vrints C, Schuler G, Ceglarek U, Thiery J, Zeymer U; CULPRIT-SHOCK Investigators.. Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial. Am Heart J. 2016 Feb;172:160-9. IF 4.332
Tscharre M, Hauser C, Rohla M, Freynhofer MK, Wojta J, Huber K, Weiss TW. Epicardial adipose tissue and cardiovascular outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2016.
Vafaie M, Slagman A, Möckel M, Hamm C, Huber K, Müller C, Vollert JO, Blankenberg S, Katus HA, Liebetrau C, Giannitsis E, Searle J. Prognostic value of undetectable hs troponin T in suspected acute coronary syndrome. Am J Med. 2016 Mar;129(3):274-82. IF 5.610
van Slochteren FJ, van Es R, Gyöngyösi M, van der Spoel TI, Koudstaal S, Leiner T, Doevendans PA, Chamuleau SA. Three dimensional fusion of electromechanical mapping and magnetic resonance imaging for real-time navigation of intramyocardial cell injections in a porcine model of chronic myocardial infarction. Int J Cardiovasc Imaging. 2016 May;32(5):833-43. IF 1.880
Vranckx P, White HD, Huang Z, Mahaffey KW, Armstrong PW, Van de Werf F, Moliterno DJ, Wallentin L, Held C, Aylward PE, Cornel JH, Bode C, Huber K, Nicolau JC, Ruzyllo W, Harrington RA, Tricoci P. Validation of BARC bleeding criteria in patients with acute coronary syndromes: the TRACER trial. J Am Coll Cardiol. 2016 May 10;67(18):2135-44. IF 17.759
Weber C, Shantsila E, Hristov M, Caligiuri G, Guzik T, Heine GH, Hoefer IE, Monaco C, Peter K, Rainger E, Siegbahn A, Steffens S, Wojta J, Lip GY. Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups “Atherosclerosis & Vascular Biology” and “Thrombosis”. Thromb Haemost. 2016 Sep 27;116(4):626-37. IF 5.255
Weiss TW, Aichinger J, Huber K, Speidl WS, Watzinger N, Zweiker R, Alber HF. Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction. Wien Klin Wochenschr. 2016 Jun;128(11-12):450-7. IF 0.836
Winter MP, Wiesbauer F, Alimohammadi A, Blessberger H, Pavo N, Schillinger M, Huber K, Wojta J, Lang IM, Maurer G, Goliasch G. Soluble galectin-3 is associated with premature myocardial infarction. Eur J Clin Invest. 2016 May;46(5):386-91. IF 2.687
Wonnerth A, Krychtiuk KA, Mayer FJ, Minar E, Wojta J, Schillinger M, Koppensteiner R, Hoke M. Red cell distribution width and mortality in carotid atherosclerosis. Eur J Clin Invest. 2016 Feb;46(2):198-204. IF 2.687
Wu J, Hafner C, Schramel JP, Kaun C, Krychtiuk KA, Wojta J, Boehme S, Ullrich R, Tretter EV, Markstaller K, Klein KU. Cyclic and constant hyperoxia cause inflammation, apoptosis and cell death in human umbilical vein endothelial cells. Acta Anaesthesiol Scand. 2016 Apr;60(4):492-501. IF 2.049
Wu J, Stefaniak J, Hafner C, Schramel JP, Kaun C, Wojta J, Ullrich R, Tretter VE, Markstaller K, Klein KU. Intermittent hypoxia causes inflammation and injury to human adult cardiac myocytes. Anesth Analg. 2016 Feb;122(2):373-80. IF 3.827

Publications of the LBC for Cardiovascular Research 2015

Publications ASC:

Granegger M, Masetti M, Laohasurayodhin R, Schloglhofer T, Zimpfer D, Schima H, Moscato F. Continuous monitoring of aortic valve opening in rotary blood pump patients. IEEE Trans Biomed Eng. 2015 Oct 9. [Epub ahead of print] PubMed PMID: 26461795. IF: 2.347
Hayward C, Lim CP, Schima H, Macdonald P, Moscato F, Muthiah K, Granegger M. Pump Speed Waveform Analysis to Detect Aortic Valve Opening in Patients on Ventricular Assist Device Support. Artif Organs. 2015;39:704-9. IF: 2.05
Mazza G, Stoiber M, Pfeiffer D, Schima H. Atraumatic Pulsatile Leukocyte Circulation for Long-Term In Vitro Dynamic Culture and Adhesion Assays. Artif Organs. 2015;39:973-8. IF: 2050
Stoiber M, Messner B, Grasl C, Gschlad V, Bergmeister H, Bernhard D, Schima H. A method for mechanical characterization of small blood vessels and vascular grafts. Experimental Mechanics. 2015; 55:1591–1595. IF: 1.548

Publications INFO:

Gyöngyösi M, Wojakowski W, Lemarchand P, Lunde K, Tendera M, Bartunek J, Marban E, Assmus A, Henry TD, Traverse JH, Moyé LA, Sürder D, Corti R, Huikuri H, Miettinen J, Wöhrle J, Obradovic S, Roncalli J, Malliaras K, Pokushalov E, Romanov A, Kastrup J, Bergmann MW, Atsma DE, Diederichsen A, Edes I, Benedek I, Benedek T, Pejkov H, Nyolczas N, Pavo N, Bergler-Klein J, Pavo IJ, Sylven C, Berti S, NavareseEP, Maurer G, for the ACCRUE investigators. Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res. 2015;116:1346-60. IF: 11.019
Katsaros KM, Speidl WS, Demyanets S, Kastl SP, Krychtiuk KA, Wonnerth A, Zorn G, Tentzeris I, Farhan S, Maurer G, Wojta J, Huber K. G-CSF predicts cardiovascular events in patients with stable coronary artery disease. PLoS One. 2015;10:e0142532. IF: 3.234
Kozarov E, Huber K, Wojta J. Infection-associated biomarkers of inflammation in atherosclerosis. Curr Pharm Des. 2015;21:1776-82. IF: 3.452
Krychtiuk KA, Kastl SP, Hofbauer SL, Wonnerth A, Goliasch G, Ozsvar-Kozma M, Katsaros KM, Maurer G, Huber K, Dostal E, Binder CJ, Pfaffenberger S, Oravec S, Wojta J, Speidl WS. Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a). J Clin Lipidol. 2015;9:533-41. IF: 3.904
Krychtiuk KA, Kastl SP, Pfaffenberger S, Lenz M, Hofbauer SL, Wonnerth A, Koller L, Katsaros KM, Pongratz T, Goliasch G, Niessner A, Gaspar L, Huber K, Maurer G, Dostal E, Wojta J, Oravec S, Speidl WS. Association of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease. PLoS One. 2015;10:e0123367. IF: 3.234
Krychtiuk KA, Ruhittel S, Hohensinner PJ, Koller L, Kaun C, Lenz M, Bauer B, Wutzlhofer L, Draxler DF, Maurer G, Huber K, Wojta J, Heinz G, Niessner A, Speidl WS. Mitochondrial DNA and toll-like receptor-9 are associated with mortality in critically ill Patients. Crit Care Med. 2015;43:2633-41. IF: 6.312
Krychtiuk KA, Watzke L, Kaun C, Buchberger E, Hofer-Warbinek R, Demyanets S, Pisoni J, Kastl SP, Rauscher S, Gröger M, Aliabadi A, Zuckermann A, Maurer G, de Martin R, Huber K, Wojta J, Speidl WS. Levosimendan exerts anti-inflammatory effects on cardiac myocytes and endothelial cells in vitro. Thromb Haemost. 2015;113:350-62. IF: 4.984
Stojkovic S, Ristl R, Moser FT, Wolzt M, Wojta J, Schmidinger H, Pezawas T. T-wave variability for the prediction of fast ventricular arrhythmias – prospective, observer-blind study. Circ J. 2015;79:318-24. IF: 3.940
Wojta J. Platelet-derived microparticles in patients with high cardiovascular risk and subclinical atherosclerosis. Thromb Haemost. 2015;114:1099. IF: 4.984

Publications REM:

Santer D, Nagel F, Kreibich M, Dzilic E, Moser PT, Muschitz G, Inci M, Krssak M, Plasenzotti P, Bergmeister H, Trescher K, Podesser BK. In vivo and ex vivo functional characterization of left ventricular remodelling after myocardial infarction in mice. ESC Heart Failure. 2015;2:171-177.
Trescher K, Dzilic E, Kreibich M, Gasser H, Aumayr K, Kerjaschki D, Pelzmann B, Hallström S, Podesser BK. The nitric oxide donor, S-nitroso human serum albumin, as an adjunct to HTK-N cardioplegia improves protection during cardioplegic arrest after myocardial infarction in rats. Interact Cardiovasc Thorac Surg. 2015;20:387-94. IF: 1.155

Publications BIO:

Andric T, Weiss TW, Huber K, Arnesen H, Seljeflot I. Effects of diet and/or n-3 fatty acid supplementation on components of the interleukin-6 trans-signalling system in elderly men. Scand J Clin Lab Invest. 2015;75:646-51. IF: 1.989
Aradi D, Collet JP, Mair J, Plebani M, Merkely B, Jaffe AS, Möckel M, Giannitsis E, Thygesen K, ten Berg JM, Mueller C, Storey RF, Lindahl B, Huber K; Study Group on Biomarkers in Cardiology of the Acute Cardiovascular Care Association of the European Society of Cardiology; Working Group on Thrombosis of the European Society of Cardiology. Platelet function testing in acute cardiac care – is there a role for prediction or prevention of stent thrombosis and bleeding? Thromb Haemost. 2015;113:221-30. IF: 4.984
Freynhofer MK, Gruber SC, Grove EL, Weiss TW, Wojta J, Huber K. Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testing. Thromb Haemost. 2015;114:459-68. IF: 4.984
Huber K. Prasugrel in clopidogrel nonresponders: a way to improve secondary prevention in patients after percutaneous coronary intervention? JACC Cardiovasc Interv. 2015;8:1571-3. IF: 7.345
Jäger B, Farhan S, Kalla K, Glogar HD, Christ G, Karnik R, Norman G, Prachar H, Schreiber W, Kaff A, Podczeck-Schweighofer A, Weidinger F, Stefenelli T, Delle-Karth G, Laggner AN, Maurer G, Huber K; Vienna STEMI Registry Group. One-year mortality in patients with acute ST-elevation myocardial infarction in the Vienna STEMI registry. Wien Klin Wochenschr. 2015;127:535-42. IF: 0.836
Rohla M, Vennekate CK, Tentzeris I, Freynhofer MK, Farhan S, Egger F, Weiss TW, Wojta J, Granger CB, Huber K. Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery disease. Int J Cardiol. 2015;184:108-14. IF: 4.036
Schrör K, Huber K. Platelets, inflammation and anti-inflammatory drugs in ACS and CAD. Thromb Haemost. 2015;114:446-8. IF: 4.984
Siller-Matula JM, Trenk D, Schrör K, Gawaz M, Kristensen SD, Storey RF, Huber K; European Platelet Academy. How to improve the concept of individualised antiplatelet therapy with P2Y12 receptor inhibitors–is an algorithm the answer? Thromb Haemost. 2015;113:37-52. IF: 4.984

Publications SDG:

Bergmeister H, Seyidova N, Schreiber C, Strobl M, Grasl C, Walter I, Messner B, Baudis S, Fröhlich S, Marchetti-Deschmann M, Griesser M, di Franco M, Krssak M, Liska R, Schima H. Biodegradable, thermoplastic polyurethane grafts for small diameter vascular replacements. Acta Biomater. 2015;11:104-13. IF: 6.025

Associated publications of the LBC for Cardiovascular Research 2015

Original papers and reviews on which PIs or project-associated co-workers appear as co-authors (highlighted in bold) are considered to be associated publications of the cluster and are listed below.

Andreotti F, Rocca B, Husted S, Ajjan RA, ten Berg J, Cattaneo M, Collet JP, De Caterina R, Fox KA, Halvorsen S, Huber K, Hylek EM, Lip GY, Montalescot G, Morais J, Patrono C, Verheugt FW, Wallentin L, Weiss TW, Storey RF; ESC Thrombosis Working Group. Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J. 2015;36:3238-49. IF: 15.203
Aradi D, Kirtane A, Bonello L, Gurbel PA, Tantry US, Huber K, Freynhofer MK, ten Berg J, Janssen P, Angiolillo DJ, Siller-Matula JM, Marcucci R, Patti G, Mangiacapra F, Valgimigli M, Morel O, Palmerini T, Price MJ, Cuisset T, Kastrati A, Stone GW, Sibbing D. Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. Eur Heart J. 2015;36:1762-71. IF: 15.203
Aulin J, Siegbahn A, Hijazi Z, Ezekowitz MD, Andersson U, Connolly SJ, Huber K, Reilly PA, Wallentin L, Oldgren J. Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation. Am Heart J. 2015;170:1151-60. IF: 4.463
Beer L, Zimmermann M, Mitterbauer A, Ellinger A, Gruber F, Narzt MS, Zellner M, Gyöngyösi M, Madlener S, Simader E, Gabriel C, Mildner M, Ankersmit HJ. Analysis of the secretome of apoptotic peripheral blood mononuclear cells: impact of released proteins and exosomes for tissue regeneration. Sci Rep. 2015;5:16662. IF: 5.578
Beitzke D, Berger-Kulemann V, Schöpf V, Unterhumer S, Spitzer E, Feuchtner GM, Gyöngyösi M, Uyanik-Uenal K, Zuckermann A, Loewe C, Wolf F. Dual-source cardiac computed tomography angiography (CCTA) in the follow-up of cardiac transplant: comparison of image quality and radiation dose using three different imaging protocols. Eur Radiol. 2015;25:2310-7. IF: 4.014
Boriani G, Lane DA, Windecker S, Huber K, Kirchhof P, Lip GY. Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice. Europace. 2015;17:1319-22. IF: 3.670
Capodanno D, Lip GY, Windecker S, Huber K, Kirchhof P, Boriani G, Lane D, Gilard M, Collet JP, Valgimigli M, Byrne RA. Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement. EuroIntervention. 2015;10:1015-21. IF: 3.322
Clemmensen P, Roe MT, Hochman JS, Cyr DD, Neely ML, McGuire DK, Cornel JH, Huber K, Zamoryakhin D, White HD, Armstrong PW, Fox KA, Prabhakaran D, Ohman EM; TRILOGY ACS Investigators. Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial. Am Heart J. 2015;170:695-705. IF: 4.463
De Luca G, Van’t Hof AW, Gibson IF: 4.463CM, Cutlip D, Zeymer U, Noc M, Maioli M, Zorman S, Gabriel HM, Emre A, Rakowski T, Gyongyosi M, Huber K, Bellandi F, Dudek D; EGYPT cooperation. Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation). Am J Cardiol. 2015;115:711-5. IF: 3.276
Distelmaier K, Wiesbauer F, Blessberger H, Oravec S, Schrutka L, Binder C, Dostal E, Schillinger M, Wojta J, Lang IM, Maurer G, Huber K, Goliasch G. Impaired antioxidant HDL function is associated with premature myocardial infarction. Eur J Clin Invest. 2015;45:731-8. IF: 2.734
Duschek N, Stojakovic T, Ghai S, Strassegger J, Basic J, Scharnagl H, Falkensammer J, Huber K, Assadian A. Ratio of apolipoprotein A-II/B improves risk prediction of postoperative survival after carotid endarterectomy. Stroke. 2015;46:1700-3. IF: 5.761
Falkensammer J, Frech A, Duschek N, Gasteiger S, Stojakovic T, Scharnagl H, Huber K, Fraedrich G, Greiner A. Prognostic relevance of ischemia-modified albumin and NT-proBNP in patients with peripheral arterial occlusive disease. Clin Chim Acta.;438:255-60. IF: 2.824
Fröhlich SM, Eilenberg M, Svirkova A, Grasl C, Liska R, Bergmeister H, Marchetti-Deschmann M. Mass spectrometric imaging of in vivo protein and lipid adsorption on biodegradable vascular replacement systems. Analyst. 2015;140:6089-99. IF: 4.107
Gershlick AH, Westerhout CM, Armstrong PW, Huber K, Halvorsen S, Steg PG, Ostojic M, Goldstein P, Carvalho AC, Van de Werf F, Wilcox RG. Impact of a pharmacoinvasive strategy when delays to primary PCI are prolonged. Heart. 2015;101:692-8. IF: 5.595
Goliasch G, Wiesbauer F, Blessberger H, Demyanets S, Wojta J, Huber K, Maurer G, Schillinger M, Speidl WS. Premature myocardial infarction is strongly associated with increased levels of remnant cholesterol. J Clin Lipidol. 2015;9:801-6. IF: 3.904
Gorenek B, Blomström Lundqvist C, Brugada Terradellas J, Camm AJ, Hindricks G, Huber K, Kirchhof P, Kuck KH, Kudaiberdieva G, Lin T, Raviele A, Santini M, Tilz RR, Valgimigli M, Vos MA, Vrints C, Zeymer U. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. EuroIntervention. 2015;10:1095-108. IF: 3.322
Gorenek B, Lundqvist CB, Terradellas JB, Camm AJ, Hindricks G, Huber K, Kirchhof P, Kuck KH, Kudaiberdieva G, Lin T, Raviele A, Santini M, Tilz RR, Valgimigli M, Vos MA, Vrints C, Zeymer U. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Eur Heart J Acute Cardiovasc Care. 2015;4:386.
Haider T, Höftberger R, Rüger B, Mildner M, Blumer R, Mitterbauer A, Buchacher T, Sherif C, Altmann P, Redl H, Gabriel C, Gyöngyösi M, Fischer MB, Lubec G, Ankersmit HJ. The secretome of apoptotic human peripheral blood mononuclear cells attenuates secondary damage following spinal cord injury in rats. Exp Neurol. 2015;267:230-42. IF: 4.694
Helseth R, Weiss TW, Opstad TB, Siegbahn A, Solheim S, Freynhofer MK, Huber K, Arnesen H, Seljeflot S. Associations between circulating proteins and corresponding genes expressed in coronary thrombi in patients with acute myocardial infarction. Thromb Res. 2015;136:1240-4. IF: 2.447
Helseth R, Seljeflot I, Opstad T, Solheim S, Freynhofer M, Arnesen H, Huber K, Weiss T. Genes expressed in coronary thrombi are associated with ischemic time in patients with acute myocardial infarction. Thromb Res. 2015;135:329-33. IF: 2.447
Jugdaohsingh R, Kessler K, Messner B, Stoiber M, Pedro LD, Schima H, Laufer G, Powell JJ, Bernhard D. Dietary Silicon Deficiency Does Not Exacerbate Diet-Induced Fatty Lesions in Female ApoE Knockout Mice. J Nutr. 2015;145:1498-506. IF: 3.875
Koller L, Rothgerber DJ, Sulzgruber P, El-Hamid F, Förster S, Wojta J, Goliasch G, Maurer G, Niessner A. History of previous bleeding and C-reactive protein improve assessment of bleeding risk in elderly patients (≥ 80 years) with myocardial infarction. Thromb Haemost. 2015;114:1085-91. IF: 4.984
Möckel M, Searle J, Hamm C, Slagman A, Blankenberg S, Huber K, Katus H, Liebetrau C, Müller C, Muller R, Peitsmeyer P, von Recum J, Tajsic M, Vollert JO, Giannitsis E. Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J. 2015;36:369-76. IF: 15.203
Pellaton C, Cayla G, Silvain J, Zeymer U, Cohen M, Goldstein P, Huber K, Pollack C Jr, Kerneis M, Collet JP, Vicaut E, Montalescot G; ATOLL Investigators. Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up trial. Am Heart J. 2015;170:778-86. IF: 4.463
Piechota-Polanczyk A, Demyanets S, Mittlboeck M, Hofmann M, Domenig CM, Neumayer C, Wojta J, Klinger M, Nanobachvili J, Huk I. The influence of simvastatin on NGAL, matrix metalloproteinases and their tissue inhibitors in human intraluminal thrombus and abdominal aortic aneurysm tissue. Eur J Vasc Endovasc Surg. 2015;49:549-55. IF: 2.490
Rubboli A, Agewall S, Huber K, Lip GY. New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint. Int J Cardiol. 2015;196:133-8. IF: 4.036
Rungatscher A, Hallström S, Linardi D, Milani E, Gasser H, Podesser BK, Scarabelli TM, Luciani GB, Faggian G. S-nitroso human serum albumin attenuates pulmonary hypertension, improves right ventricular-arterial coupling, and reduces oxidative stress in a chronic right ventricle volume overload model. J Heart Lung Transplant. 2015;34:479-88. IF: 6.650
Schuh, CM, Morton TJ, Banerjee A, Grasl C, Schima H, Schmidhammer R, Redl H, Ruenzler D. Activated Schwann cell-like cells on aligned fibrin-poly(lactic-co-glycolic acid) structures: a novel construct for application in peripheral nerve regeneration. Cells Tissues Organs. 2015;200:287-299. IF: 2.137
Shavadia J, Zheng Y, Dianati Maleki N, Huber K, Halvorsen S, Goldstein P, Gershlick AH, Wilcox R, Van de Werf F, Armstrong PW. Infarct size, shock, and heart failure: does reperfusion strategy matter in early presenting patients with ST-segment elevation myocardial infarction? J Am Heart Assoc. 2015;4:e002049. IF: 4.306
Springer A, Kratochwill K, Bergmeister H, Csaicsich D, Huber J, Mayer B, Mühlberger I, Stahlschmidt J, Subramaniam R, Aufricht C. A fetal sheep model for studying compensatory mechanisms in the healthy contralateral kidney after unilateral ureteral obstruction. J Pediatr Urol. 2015;11:352.e1-7. IF: 0.898
Sulzgruber P, Koller L, Reiberger T, El-Hamid F, Forster S, Rothgerber DJ, Goliasch G, Wojta J, Niessner A. Butyrylcholinesterase predicts cardiac mortality in young patients with acute coronary syndrome. PLoS One. 2015;10:e0123948. IF: 3.234

Publications of the LBC for Cardiovascular Research 2014

Publications ASC:

Granegger M, Schima H, Zimpfer D, Moscato F. Assessment of aortic valve opening during rotary blood pump support using pump signals. Artif Organs. 2014 Apr;38(4):290-7. IF 1.870 Schima H, Stoiber M, Schlöglhofer T, Hartner Z, Haberl T, Zimpfer D. Repair of left ventricular assist device driveline damage directly at the transcutaneous exit site. Artif Organs. 2014 May;38(5):422-5. IF 1.870
Juraszek A, Dziodzio T, Stoiber M, Fechtig D, Gschlad V, Aigner P, Czerny M, Schima H. The influence of bicuspid aortic valves on the dynamic pressure distribution in the ascending aorta: a porcine ex vivo model. Eur J Cardiothorac Surg. 2014 Sep;46(3):349-55; discussion 355. IF 3.048
Moscato F, Granegger M, Edelmayer M, Zimpfer D, Schima H. Continuous monitoring of cardiac rhythms in left ventricular assist device patients. Artif Organs. 2014 Mar;38(3):191-8. IF 1.870
Schima H, Schlöglhofer T, zu Dohna R, Drews T, Morshuis M, Roefe D, Schmitto JD, Strüber M, Zimpfer D. Usability of ventricular assist devices in daily experience: a multicenter study. Artif Organs. 2014 Sep;38(9):751-60. IF 1.870
Schima H, Zrunek P, Stoiber M, Larose J, Shambaugh C, Tamez D, Deckert Z, Plasenzotti R, Bergmeister H, Wieselthaler G. Extended in vivo evaluation of a miniaturized axial flow pump with a novel inflow cannula for a minimal invasive implantation procedure. J Heart Lung Transplant. 2014 Apr;33(4):422-8. IF 5.611
Schlöglhofer T, Gilly H, Schima H. Semi-invasive measurement of cardiac output based on pulse contour: a review and analysis. Can J Anaesth. 2014 May;61(5):452-79. IF 2.495

Publications INFO:

Demyanets S, Tentzeris I, Jarai R, Katsaros KM, Farhan S, Wonnerth A, Weiss TW, Wojta J, Speidl WS, Huber K. An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis. Cytokine. 2014 Jun;67(2):65-70. IF 2.847
Demyanets S, Speidl WS, Tentzeris I, Jarai R, Katsaros KM, Farhan S, Krychtiuk KA, Wonnerth A, Weiss TW, Huber K, Wojta J. Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome. PLoS One. 2014 Apr 21;9(4):e95055. IF 3.534
Katsaros KM, Kastl SP, Krychtiuk KA, Hutter R, Zorn G, Maurer G, Huber K, Wojta J, Christ G, Speidl WS. An increase of VEGF plasma levels is associated with restenosis of drug-eluting stents. EuroIntervention. 2014 Jun;10(2):224-30. IF 3.758
Krychtiuk KA, Nürnberg M, Volker R, Pachinger L, Jarai R, Freynhofer MK, Wojta J, Huber K, Weiss TW. Effects of AV-delay optimization on hemodynamic parameters in patients with VDD pacemakers. Wien Klin Wochenschr. 2014 May;126(9-10):270-7. IF 0.791
Krychtiuk KA, Kastl SP, Pfaffenberger S, Pongratz T, Hofbauer SL, Wonnerth A, Katsaros KM, Goliasch G, Gaspar L, Huber K, Maurer G, Dostal E, Oravec S, Wojta J, Speidl WS. Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease. Atherosclerosis. 2014 Dec;237(2):589-96. IF 3.991
Pavo N, Charwat S, Nyolczas N, Jakab A, Murlasits Z, Bergler-Klein J, Nikfardjam M, Benedek I, Benedek T, Pavo IJ, Gersh BJ, Huber K, Maurer G, Gyöngyösi M. Cell therapy for human ischemic heart diseases: Critical review and summary of the clinical experiences. J Mol Cell Cardiol. 2014;75:12-24. IF 5.218
Pavo N, Emmert MY, Giricz Z, Varga ZV, Ankersmit HJ, Maurer G, Hoerstrup SP, Ferdinandy P, Wu JC, Gyöngyösi M. Real-time visualization of ischemic burden during repetitive ischemia/reperfusion. JACC Cardiovasc Imaging 20142014 Sep;7(9):956-8. IF 6.986
Pavo N, Jakab A, Emmert MY, Strebinger G, Wolint P, Zimmermann M, Ankersmit HJ, Hoerstrup SP, Maurer G, Gyöngyösi M. Comparison of NOGA endocardial mapping and cardiac magnetic resonance imaging for determining infarct size and infarct transmurality for intramyocardial injection therapy using experimental data. PLoS One. 2014;9(11):e113245. IF 3.534
Pavo N, Zimmermann M, Pils D, Mildner M, Petrási Z, Petneházy O, Fuzik J, Jakab A, Gabriel C, Sipos W, Maurer G, Gyöngyösi M*, Ankersmit HJ. Long-acting beneficial effect of percutaneously intramyocardially delivered secretome of apoptotic peripheral blood cells on porcine chronic ischemic left ventricular dysfunction. Biomaterials. 2014 Apr;35(11):3541-50. *equally contributed to last authorship IF 8.312
Stojkovic S, Kaun C, Heinz M, Krychtiuk KA, Rauscher S, Lemberger CE, de Martin R, Gröger M, Petzelbauer P, Huk I, Huber K, Wojta J, Demyanets S. Interleukin-33 induces urokinase in human endothelial cells–possible impact on angiogenesis. J Thromb Haemost. 2014 Jun;12(6):948-57. IF 5.550
Wonnerth A, Katsaros KM, Krychtiuk KA, Speidl WS, Kaun C, Thaler K, Huber K, Wojta J, Maurer G, Seljeflot I, Arnesen H, Weiss TW. Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels. Metabolism. 2014 May;63(5):647-53. IF 0

Publications BIO:

Egger F, Nürnberg M, Rohla M, Weiss TW, Unger G, Smetana P, Geppert A, Gruber SC, Bambazek A, Falkensammer J, Waldenberger FR, Huber K, Freynhofer MK. High-degree atrioventricular block in patients with preexisting bundle branch block or bundle branch block occurring during transcatheter aortic valve implantation. Heart Rhythm. 2014 Dec;11(12):2176-82. IF 4.918
Freynhofer MK, Bruno V, Brozovic I, Jarai R, Vogel B, Farhan S, Hübl W, Willheim M, Wojta J, Huber K. Variability of on-treatment platelet reactivity in patients on clopidogrel. Platelets. 2014;25(5):328-36. IF 2.627
Halvorsen S, Huber K. Fibrinolytic treatment of ST-elevation myocardial infarction. Update 2014. Hamostaseologie. 2014 Feb 4;34(1):47-53. IF 1.589
Höchtl T, Huber K. P2Y12-receptor-inhibiting antiplatelet strategies in acute coronary syndromes. Hamostaseologie. 2014 Feb 4;34(1):20-8. IF 1.589
Höchtl-Hainzl T, Huber K. Direct anticoagulants for atrial fibrillation. Update 2014. Herz. 2014 May;39(3):357-67. IF 0.912
Huber K, Bates ER, Valgimigli M, Wallentin L, Kristensen SD, Anderson JL, Lopez Sendon JL, Tubaro M, Granger CB, Bode C, Ohman EM, Steg PG. Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold? Am Heart J. 2014 Nov;168(5):611-21. IF 4.555
Rohla M, Freynhofer MK, Hammerl H, Weiss TW, Huber K. Stroke and recurrent left atrial appendage thrombus in a patient with atrial fibrillation under old and new oral anticoagulants: a case report. Thromb Haemost. 2014 Feb;111(2):375-8. IF 5.760
Rohla M, Freynhofer MK, Tentzeris I, Farhan S, Wojta J, Huber K, Weiss TW. Plasma osmolality predicts clinical outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2014 Mar;3(1):84-92. IF 0
Tentzeris I, Rohla M, Jarai R, Farhan S, Freynhofer MK, Unger G, Nürnberg M, Geppert A, Wessely E, Wojta J, Huber K. Influence of high-dose highly efficient statins on short-term mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary syndromes. Am J Cardiol. 2014 Apr 1;113(7):1099-104. IF 3.425

Publications SDG:

Sherif C, Kleinpeter G, Mach G, Loyoddin M, Haider T, Plasenzotti R, Bergmeister H, Di Ieva A, Gibson D, Krssak M. Evaluation of cerebral aneurysm wall thickness in experimental aneurysms: comparison of 3T-MR imaging with direct microscopic measurements. Acta Neurochir (Wien). 2014 Jan;156(1):27-34. IF 1.788

Associated publications of the LBC for Cardiovascular Research 2014

Original papers and reviews on which PIs or project-associated co-workers appear as co-authors (highlighted in bold) are considered to be associated publications of the cluster and are listed below.

Adlbrecht C, Huber K, Reynolds HR, Carvalho AC, Džavík V, Steg PG, Liu L, Marino P, Pearte CA, Rankin JM, White HD, Lamas GA, Hochman JS. Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction. Int J Cardiol. 2014 Jun 1;174(1):90-5. TOP 10% IF 6.175
Alias S, Redwan B, Panzenböck A, Winter MP, Schubert U, Voswinckel R, Frey MK, Jakowitsch J, Alimohammadi A, Hobohm L, Mangold A, Bergmeister H, Sibilia M, Wagner EF, Mayer E, Klepetko W, Hölzenbein TJ, Preissner KT, Lang IM. Defective angiogenesis delays thrombus resolution: a potential pathogenetic mechanism underlying chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):810-9. IF 5.550
Aradi D, Storey RF, Komócsi A, Trenk D, Gulba D, Kiss RG, Husted S, Bonello L, Sibbing D, Collet JP, Huber K; Working Group on Thrombosis of the European Society of Cardiology. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention. Eur Heart J. 2014 Jan;35(4):209-15. TOP 10% IF 14.723
Balogh A, Santer D, Pásztor ET, Tóth A, Czuriga D, Podesser BK, Trescher K, Jaquet K, Erdodi F, Edes I, Papp Z. Myofilament protein carbonylation contributes to the contractile dysfunction in the infarcted LV region of mouse hearts. Cardiovasc Res. 2014 Jan 1;101(1):108-19. IF 5.808
Beer L, Seemann R, Ristl R, Ellinger A, Kasiri MM, Mitterbauer A, Zimmermann M, Gabriel C, Gyöngyösi M, Klepetko W, Mildner M, Ankersmit HJ. High dose ionizing radiation regulates micro RNA and gene expression changes in human peripheral blood mononuclear cells. BMC Genomics. 2014 Sep 25;15:814. IF 4.041
Bergler-Klein J, Gyöngyösi M, Maurer G. The role of biomarkers in valvular heart disease: focus on natriuretic peptides. Can J Cardiol. 2014;30:1027-34. IF 3.940
Gouya G, Arrich J, Wolzt M, Huber K, Verheugt FW, Gurbel PA, Pirker-Kees A, Siller-Matula JM. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis. Stroke. 2014 Feb;45(2):492-503. TOP 10% IF 6.018
Haberl T, Riebandt J, Mahr S, Laufer G, Rajek A, Schima H, Zimpfer D. Viennese approach to minimize the invasiveness of ventricular assist device implantation. Eur J Cardiothorac Surg. 2014 Dec;46(6):991-6; discussion 996 IF 3.048
Koller L, Blum S, Korpak M, Richter B, Goliasch G, Zorn G, Brekalo M, Maurer G, Wojta J, Pacher R, Hülsmann M, Niessner A. Predictive power of the fractalkine receptor CX3CR1 on CD4 T cells in patients with chronic heart failure. Int J Cardiol. 2014 Jan 15;171(1):96-7. TOP 10%, IF 6.175
Krenn L, Kopp C, Glogar D, Lang IM, Delle-Karth G, Neunteufl T, Kreiner G, Kaider A, Bergler-Klein J, Khorsand A, Nikfardjam M, Laufer G, Maurer G, Gyöngyösi M. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention. Catheter Cardiovasc Interv. 2014 Dec 1;84(7):1029-39. IF 0
Kyrle PA, Binder K, Eichinger S, Függer R, Gollackner B, Hiesmayr JM, Huber K, Lang W, Perger P, Quehenberger P, Roithinger FX, Schmaldienst S, Weltermann A, Domanovits H. Dabigatran: patient management in specific clinical settings. Wien Klin Wochenschr. 2014 Sep;126(17-18):503-8. IF 0.791
Lichtenauer M, Schreiber C, Jung C, Beer L, Mangold A, Gyöngyösi M, Podesser BK, Ankersmit HJ. Myocardial infarct size measurement using geometric angle calculation. Eur J Clin Invest. 2014 Feb;44(2):160-7. IF 2.834
Riebandt J, Haberl T, Mahr S, Laufer G, Rajek A, Steinlechner B, Schima H, Zimpfer D. Preoperative patient optimization using extracorporeal life support improves outcomes of INTERMACS Level I patients receiving a permanent ventricular assist device. Eur J Cardiothorac Surg. 2014 Sep;46(3):486-92; discussion 492. IF 3.048
Riebandt J, Haberl T, Mahr S, Rajek A, Laufer G, Schima H, Zimpfer D. Off-pump HeartWare ventricular assist device implantation with outflow graft anastomosis to the left subclavian artery. Ann Thorac Surg. 2014 Jun;97(6):2214-6. IF 3.631
Sandner SE, Riebandt J, Haberl T, Mahr S, Rajek A, Schima H, Wieselthaler GM, Laufer G, Zimpfer D. Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation. J Heart Lung Transplant. 2014 Jan;33(1):88-93. IF 5.611

Publications of the LBC for Cardiovascular Research 2013

Publications ASC:

Aigner P, Eskandary F, Schlöglhofer T, Gottardi R, Aumayr K, Laufer G, Schima H. Sternal force distribution during median sternotomy retraction. J Thorac Cardiovasc Surg. 2013;146:1381-6. IF: 3.526
Granegger M, Mahr S, Horvat J, Aigner P, Roehrich M, Stoiber M, Plasenzotti R, Zimpfer D, Schima H, Moscato F. Investigation of hemodynamics in the assisted isolated porcine heart. Int J Artif Organs. 2013;36:878-86. IF: 1.759
Moscato F, Wirrmann C, Granegger M, Eskandary F, Zimpfer D, Schima H. Use of continuous flow ventricular assist devices in patients with heart failure and a normal ejection fraction: a computer-simulation study. J Thorac Cardiovasc Surg. 2013;145:1352-8. IF: 3.526
Schima H, Schlöglhofer T, Hartner Z, Horvat J, Zimpfer D. Importance of linguistic details in alarm messages of ventricular assist devices. Int J Artif Organs. 2013;36:406-9. IF: 1.759
Schlöglhofer T, Aigner P, Stoiber M, Schima H. Fixation and mounting of porcine aortic valves for use in mock circuits. Int J Artif Organs. 2013;36:738-41. IF: 1.759
Stoiber M, Schlöglhofer T, Aigner P, Grasl C, Schima H. An alternative method to create highly transparent hollow models for flow visualization. Int J Artif Organs. 2013;36(2):131-4. IF: 1.75

Publications INFO:

Alessi MC, Wojta J. Obesity and vascular disease: from bench to bedside. Thromb Haemost. 2013;110:632-3. IF: 6.094
Demyanets S, Kaun C, Pentz R, Krychtiuk KA, Rauscher S, Pfaffenberger S, Zuckermann A, Aliabadi A, Gröger M, Maurer G, Huber K, Wojta J. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature. J Mol Cell Cardiol. 2013;60:16-26. IF: 5.148
Emmert MY, Wolint P, Winklhofer S, Stolzmann P, Cesarovic N, Fleischmann T, Nguyen TD, Frauenfelder T, Böni R, Scherman J, Bettex D, Grünenfelder J, Schwartlander R, Vogel V, Gyöngyösi M*, Alkadhi H, Falk V, Hoerstrup SP. Transcatheter based electromechanical mapping guided intramyocardial transplantation and in vivo tracking of human stem cell based three dimensional microtissues in the porcine heart. Biomaterials. 2013;34:2428-41. IF: 7.4 (*Leader of MUW Project)
Krychtiuk KA, Kastl SP, Speidl WS, Wojta J. Inflammation and coagulation in atherosclerosis. Hamostaseologie. 2013;33:269-82. IF: 1.479
Pfaffenberger S, Vyskocil E, Kollmann C, Unger E, Kaun C, Kastl S, Woeber C, Nawratil G, Huber K, Maurer G, Gottsauner-Wolf M, Wojta J. Transtemporal ultrasound application potentially elevates brain temperature: results of an anthropomorphic skull model. Ultraschall Med. 2013;34:51-7. IF: 4.116
Rega-Kaun G, Kaun C, Wojta J. More than a simple storage organ: adipose tissue as a source of adipokines involved in cardiovascular disease. Thromb Haemost. 2013;110:641-50. IF: 6.094

Publications REM:

Trescher K, Hasun M, Baumgartner A, Dietl W, Wolfsberger M, Hallström S, Podesser BK. New HTK-N46B cardioplegia provides superior protection during ischemia/reperfusion in failing hearts. J Cardiovasc Surg (Torino). 2013 J;54:413-21. IF: 1.510
Trescher K, Thometich B, Demyanets S, Kassal H, Sedivy R, Bittner R, Holzinger C, Podesser BK. Type A dissection and chronic dilatation: tenascin-C as a key factor in destabilization of the aortic wall. Interact Cardiovasc Thorac Surg. 2013;17:365-70. IF: 1.112

Publications BIO:

Freynhofer MK, Bruno V, Brozovic I, Jarai R, Vogel B, Farhan S, Hübl W, Willheim M, Wojta J, Huber K. Variability of on-treatment platelet reactivity in patients on clopidogrel. Platelets. 2013. [Epub ahead of print] IF: 2.240
Freynhofer MK, Draxler DF, Gruber SC, Bruno V, Höchtl T, Fellner B, Jakl-Kotauschek G, Wojta J, Pabinger-Fasching I, Huber K, Ay C. Endogenous t-PA- antigen is an independent predictor of adverse cardiovascular events and all-cause death in patients with atrial fibrillation. J Thromb Haemost. 2013;11:1069-77. IF: 6.081
Freynhofer MK, Gruber SC, Bruno V, Höchtl T, Farhan S, Zaller V, Wojta J, Huber K. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation. Int J Cardiol. 2013;168:317-25. IF: 5.509
Siller-Matula JM, Trenk D, Schrör K, Gawaz M, Kristensen SD, Storey RF, Huber K; EPA (European Platelet Academy). Response variability to P2Y12 receptor inhibitors: expectations and reality. JACC Cardiovasc Interv. 2013;6:1111-28. IF: 6.552

Publications SDG:

Bergmeister H, Schreiber C, Grasl C, Walter I, Plasenzotti R, Stoiber M, Bernhard D, Schima H. Healing characteristics of electrospun polyurethane grafts with various porosities. Acta Biomater. 2013;9:6032-40. IF: 5.093
Bergmeister H, Strobl M, Grasl C, Liska R, Schima H. Tissue engineering of vascular grafts. Eur Surg 2013;45:187-193. IF: 0.148
Grasl C., Arras MM, Stoiber M, Bergmeister H., Schima H., Electrodynamic control of the nanofiber alignment during electrospinning. Applied Physics Letters, 2013;102:053111. IF: 3.794
Mashayekhi R, Mobedi H, Najafi J, Enayati M., In-vitro/In-vivo comparison of leuprolide release from an in-situ forming plga system, DARU J Pharmt Sci, 2013;21:57 -64. IF:0.620
Sherif C, Kleinpeter G, Mach G, Loyoddin M, Haider T, Plasenzotti R, Bergmeister H, Di Ieva A, Gibson D, Krssak M. Evaluation of cerebral aneurysm wall thickness in experimental aneurysms: comparison of 3T-MR imaging with direct microscopic measurements. Acta Neurochir (Wien). 2014;156:27-34. IF: 1.546
Strobl M, Schreiber C, Panzenböck A, Winter MP, Bergmeister H, Jakowitsch J, Mascherbauer J, Lang IM, Wexberg P, Bonderman D. Exhaled nitric oxide measurement to monitor pulmonary hypertension in a pneumonectomy-monocrotaline rat model. Am J Physiol Lung Cell Mol Physiol. 2013;305:L485-90. IF: 3.523

Associated publications of the LBC for Cardiovascular Research 2013

Original papers and reviews on which PIs or project-associated co-workers appear as co-authors (highlighted in bold) are considered to be associated publications of the cluster and are listed below.

Awad EM, Khan SY, Sokolikova B, Brunner PM, Olcaydu D, Wojta J, Breuss JM, Uhrin P. Cold induces reactive oxygen species production and activation of the NF-kappa B response in endothelial cells and inflammation in vivo. J Thromb Haemost. 2013;11:1716-26.
Balogh A, Santer D, Pásztor ET, Tóth A, Czuriga D, Podesser BK, Trescher K, Jaquet K, Erdodi F, Edes I, Papp Z. Myofilament protein carbonylation contributes to the contractile dysfunction in the infarcted LV region of mouse hearts. Cardiovasc Res. 2014;101:108-19.
Benedek T, Gyöngyösi M, Benedek I. Multislice computed tomographic coronary angiography for quantitative assessment of culprit lesions in acute coronary syndromes. Can J Cardiol. 2013;29:364-71.
Benedek I, Gyongyosi M, Benedek T. A prospective regional registry of ST-elevation myocardial infarction in Central Romania: impact of the Stent for Life Initiative recommendations on patient outcomes. Am Heart J. 2013;166:457-65.
De Luca G, Gibson M, Cutlip D, Huber K, Dudek D, Bellandi F, Noc M, Maioli M, Zorman S, Zeymer U, Secco GG, Mesquita Gabriel H, Emre A, Arntz HR, Rakowski T, Gyongyosi M, Hof AW; EGYPT Cooperation. Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors. Arch Cardiovasc Dis. 2013 Mar;106(3):155-61.
De Luca G, Gibson CM, Huber K, Dudek D, Cutlip D, Zeymer U, Gyöngyösi M, Bellandi F, Noc M, Arntz HR, Maioli M, Secco GG, Zorman S, Gabriel HM, Emre A, Rakowski T, Van’t Hof AW; EGYPT cooperation. Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. EuroIntervention. 2012;8:470-6.
De Luca G, van’t Hof AW, Huber K, Gibson CM, Bellandi F, Arntz HR, Maioli M, Noc M, Zorman S, Zeymer U, Gabriel HM, Emre A, Cutlip D, Rakowski T, Gyongyosi M, Dudek D; EGYPT cooperation. Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplasty. Am J Cardiol. 2013;112:1083-6.
Duschek N, Ghai S, Sejkic F, Falkensammer J, Skrinjar E, Huber K, Wojta J, Waldhör T, Hübl W, Assadian A. Homocysteine improves risk stratification in patients undergoing endarterectomy for asymptomatic internal carotid artery stenosis. Stroke. 2013;44:2311-4.
Koller L, Blum S, Korpak M, Richter B, Goliasch G, Zorn G, Brekalo M, Maurer G, Wojta J, Pacher R, Hülsmann M, Niessner A. Predictive power of the fractalkine receptor CX3CR1 on CD4 T cells in patients with chronic heart failure. Int J Cardiol. 2014;171:96-7.
Koller L, Richter B, Goliasch G, Blum S, Korpak M, Zorn G, Brekalo M, Maurer G, Wojta J, Pacher R, Hülsmann M, Niessner A. CD4+ CD28(null) cells are an independent predictor of mortality in patients with heart failure. Atherosclerosis. 2013;230:414-6.
Lukács E, Magyari B, Tóth L, Petneházy Ö, Petrási Z, Simor T, Gyöngyösi M, Repa I, Koller Á, Rőth E, Horváth IG. Evaluation of experimental myocardial infarction models via electromechanical mapping and magnetic resonance imaging. Can J Physiol Pharmacol. 2013;91:617-24.
Piechota-Polanczyk A, Demyanets S, Nykonenko O, Huk I, Mittlboeck M, Domenig CM, Neumayer C, Wojta J, Nanobachvili J, Klinger M. Decreased tissue levels of cyclophilin A, a cyclosporine a target and phospho-ERK1/2 in simvastatin patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2013;45:682-8.
Richter B, Koller L, Hohensinner PJ, Zorn G, Brekalo M, Berger R, Mörtl D, Maurer G, Pacher R, Huber K, Wojta J, Hülsmann M, Niessner A. A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure. Int J Cardiol. 2013;168:1251-7.
Riebandt J, Sandner S, Mahr S, Haberl T, Rajek A, Laufer G, Schima H, Zimpfer D. Minimally invasive thoratec Heartmate II implantation in the setting of severe thoracic aortic calcification. Ann Thorac Surg. 2013;96:1094-6.
Saely CH, Rein P, Vonbank A, Huber K, Drexel H. Type 2 diabetes and the progression of visualized atherosclerosis to clinical cardiovascular events. Int J Cardiol. 2013;167:776-80.
Siller-Matula JM, Delle-Karth G, Christ G, Neunteufl T, Maurer G, Huber K, Tolios A, Drucker C, Jilma B. Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin. Int J Cardiol. 2013;167:430-5.
Rohla M, Freynhofer MK, Tentzeris I, Farhan S, Wojta J, Huber K, Weiss TW. Plasma osmolality predicts clinical outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care. 2014;3:84-92.
Testori C, Holzer M, Sterz F, Stratil P, Hartner Z, Moscato F, Schima H, Behringer W. Rapid induction of mild therapeutic hypothermia by extracorporeal veno-venous blood cooling in humans. Resuscitation. 2013;84:1051-5.
Zeyda M, Wernly B, Demyanets S, Kaun C, Hämmerle M, Hantusch B, Schranz M, Neuhofer A, Itariu BK, Keck M, Prager G, Wojta J, Stulnig TM. Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. Int J Obes (Lond). 2013;37:658-65.